M E Abreu

1.1k total citations
19 papers, 920 citations indexed

About

M E Abreu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, M E Abreu has authored 19 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in M E Abreu's work include Receptor Mechanisms and Signaling (6 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Adenosine and Purinergic Signaling (4 papers). M E Abreu is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Adenosine and Purinergic Signaling (4 papers). M E Abreu collaborates with scholars based in United States, Switzerland and Spain. M E Abreu's co-authors include Sergi Munné‐Bosch, Sharon Walsh, George E. Bigelow, Eric C. Strain, Amany A.E. Ahmed, Lee A. Fleisher, John W. Ferkany, Lisa H. Conti, Roland R. Griffiths and Caroline R. Maciver and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Experimental Botany.

In The Last Decade

M E Abreu

19 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M E Abreu United States 14 413 387 209 119 82 19 920
Godfrey Tunnicliff United States 16 409 1.0× 264 0.7× 88 0.4× 110 0.9× 53 0.6× 41 851
Kulkarni Sk India 15 237 0.6× 160 0.4× 80 0.4× 73 0.6× 47 0.6× 68 566
Ricardo dos Reis Silveira Brazil 14 380 0.9× 327 0.8× 121 0.6× 98 0.8× 103 1.3× 31 941
Filipe Marques Gonçalves Brazil 19 261 0.6× 292 0.8× 81 0.4× 103 0.9× 48 0.6× 25 1.0k
Subbiah P. Sivam United States 23 1.0k 2.5× 642 1.7× 86 0.4× 234 2.0× 71 0.9× 55 1.4k
Hakan Kayır Türkiye 18 453 1.1× 330 0.9× 48 0.2× 167 1.4× 84 1.0× 58 904
Mario Eduardo Flores-Soto Mexico 19 318 0.8× 290 0.7× 103 0.5× 108 0.9× 95 1.2× 64 1.0k
Murray G. Hamilton Canada 15 298 0.7× 200 0.5× 336 1.6× 68 0.6× 38 0.5× 23 820
Mikko Uusi‐Oukari Finland 24 1.1k 2.6× 772 2.0× 67 0.3× 125 1.1× 271 3.3× 69 1.8k
Alessandra Porcu Italy 15 159 0.4× 252 0.7× 58 0.3× 84 0.7× 49 0.6× 25 808

Countries citing papers authored by M E Abreu

Since Specialization
Citations

This map shows the geographic impact of M E Abreu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M E Abreu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M E Abreu more than expected).

Fields of papers citing papers by M E Abreu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M E Abreu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M E Abreu. The network helps show where M E Abreu may publish in the future.

Co-authorship network of co-authors of M E Abreu

This figure shows the co-authorship network connecting the top 25 collaborators of M E Abreu. A scholar is included among the top collaborators of M E Abreu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M E Abreu. M E Abreu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Abreu, M E & Sergi Munné‐Bosch. (2009). Salicylic acid deficiency in NahG transgenic lines and sid2 mutants increases seed yield in the annual plant Arabidopsis thaliana. Journal of Experimental Botany. 60(4). 1261–1271. 185 indexed citations
2.
Preston, Kenzie L., Annie Umbricht, Jennifer Schroeder, et al.. (2004). Cyclazocine: comparison to hydromorphone and interaction with cocaine. Behavioural Pharmacology. 15(2). 91–102. 14 indexed citations
3.
Pickworth, Wallace B., et al.. (2004). A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug users. Pharmacology Biochemistry and Behavior. 77(4). 711–715. 5 indexed citations
4.
Walsh, Sharon, Eric C. Strain, M E Abreu, & George E. Bigelow. (2001). Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology. 157(2). 151–162. 207 indexed citations
5.
Abreu, M E, George E. Bigelow, Lee A. Fleisher, & Sharon Walsh. (2001). Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacology. 154(1). 76–84. 123 indexed citations
6.
Costa, Elı́sio, José Manuel Cabeda, M E Abreu, et al.. (2000). [Glucose-6-phosphate dehydrogenase deficiency in 2 girls].. PubMed. 12(7-11). 283–6. 1 indexed citations
7.
Abreu, M E & Roland R. Griffiths. (1996). Drug tasting may confound human drug discrimination studies. Psychopharmacology. 125(3). 255–257. 35 indexed citations
8.
Conti, Lisa H., et al.. (1994). Mouse strain differences in the behavioral effects of Corticotropin-Releasing Factor (CRF) and the CRF antagonist α-helical CRF9–41. Pharmacology Biochemistry and Behavior. 48(2). 497–503. 46 indexed citations
9.
Mewshaw, Richard E., M E Abreu, Rose Mathew, et al.. (1993). Examination of the D2/5-HT2 affinity ratios of resolved 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles: an enantioselective approach toward the design of potential atypical antipsychotics. Journal of Medicinal Chemistry. 36(21). 3073–3076. 3 indexed citations
10.
Clissold, David B., Michael J. Pontecorvo, M E Abreu, et al.. (1993). NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profile.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 876–886. 21 indexed citations
11.
Karbon, E. William, M E Abreu, David B. Clissold, et al.. (1993). NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 866–875. 23 indexed citations
12.
13.
Hiner, Roger N., Paul R. Blake, Waclaw J. Rzeszotarski, et al.. (1991). 1,3,8-Trisubstituted xanthines. Effects of substitution pattern upon adenosine receptor A1/A2 affinity. Journal of Medicinal Chemistry. 34(4). 1431–1435. 24 indexed citations
14.
Hiner, Roger N., Paul R. Blake, Waclaw J. Rzeszotarski, et al.. (1991). ChemInform Abstract: 1,3,8‐Trisubstituted Xanthines. Effects of Substitution Pattern Upon Adenosine Receptor A1/A2 Affinity.. ChemInform. 22(44). 1 indexed citations
15.
Conti, Lisa H., Caroline R. Maciver, John W. Ferkany, & M E Abreu. (1990). Footshock-induced freezing behavior in rats as a model for assessing anxiolytics. Psychopharmacology. 102(4). 492–497. 62 indexed citations
16.
Kaplita, Paul V., M E Abreu, Jane R. Connor, et al.. (1990). NPC 205 is a potent and selective adenosine A1, receptor antagonist: Correlation among receptor binding, biochemical, and physiological assays. Drug Development Research. 20(4). 429–443. 3 indexed citations
17.
Williams, Michael, M E Abreu, Michael F. Jarvis, & Lalita Noronha‐Blob. (1987). Characterization of Adenosine Receptors in the PC 12 Pheochromocytoma Cell Line Using Radioligand Binding: Evidence for A‐2 Selectivity. Journal of Neurochemistry. 48(2). 498–502. 34 indexed citations
18.
Abreu, M E & Amany A.E. Ahmed. (1980). Metabolism of acrylonitrile to cyanide. In vitro studies.. Drug Metabolism and Disposition. 8(6). 376–379. 64 indexed citations
19.
Cantrell, Elroy T., M E Abreu, & David L. Busbee. (1976). A simple assay of aryl hydrocarbon hydroxylase in cultured human lymphocytes. Biochemical and Biophysical Research Communications. 70(2). 474–479. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Godfrey Tunnicliff Breakdown of academic impact, for papers by Kulkarni Sk Breakdown of academic impact, for papers by Ricardo dos Reis Silveira Breakdown of academic impact, for papers by Filipe Marques Gonçalves Breakdown of academic impact, for papers by Subbiah P. Sivam Breakdown of academic impact, for papers by Hakan Kayır Breakdown of academic impact, for papers by Mario Eduardo Flores-Soto Breakdown of academic impact, for papers by Murray G. Hamilton Breakdown of academic impact, for papers by Mikko Uusi‐Oukari Breakdown of academic impact, for papers by Alessandra Porcu
Rankless by CCL
2026